Martine A. Rothblatt

Insider Reports History

SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ John S. Hess, Jr. under Power of Attorney
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Martine A. Rothblatt

Form 4 holding Chairperson & CEO, Director

UNITED THERAPEUTICS Corp

Security class
Stock Option
Shares / value
480,410
Estimated value
$189,202,701
Report date
08 Sep 2026
Price
$541.83
Ownership
by Trust
Underlying class
Common Stock
Underlying amount
349,192
Form 4 holding Chairperson & CEO, Director

UNITED THERAPEUTICS Corp

Security class
Stock Option
Shares / value
0
Estimated value
$16,373,018
Report date
15 Jul 2026
Price
$541.83
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,218
Form 4 holding Chairperson & CEO, Director

UNITED THERAPEUTICS Corp

Security class
Stock Options
Shares / value
500,000
Estimated value
Report date
01 Apr 2026
Price
Ownership
By Trusts
Underlying class
Common Stock
Underlying amount
Form 4 holding Chairperson & CEO, Director

UNITED THERAPEUTICS Corp

Security class
Common Stocl
Shares / value
166
Estimated value
Report date
29 Apr 2026
Price
Ownership
by Spouse
Form 4 holding Chairperson & CEO, Director

UNITED THERAPEUTICS Corp

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
15 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Martine A. Rothblatt

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .